IT1216056B - Composizioni farmaceutiche contenenti timosina alfa 1. - Google Patents

Composizioni farmaceutiche contenenti timosina alfa 1.

Info

Publication number
IT1216056B
IT1216056B IT8819731A IT1973188A IT1216056B IT 1216056 B IT1216056 B IT 1216056B IT 8819731 A IT8819731 A IT 8819731A IT 1973188 A IT1973188 A IT 1973188A IT 1216056 B IT1216056 B IT 1216056B
Authority
IT
Italy
Prior art keywords
alpha
pharmaceutical compositions
compositions containing
containing thymine
thymine
Prior art date
Application number
IT8819731A
Other languages
English (en)
Other versions
IT8819731A0 (it
Inventor
Filippo Lattanzi
Original Assignee
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo Spa filed Critical Sclavo Spa
Priority to IT8819731A priority Critical patent/IT1216056B/it
Publication of IT8819731A0 publication Critical patent/IT8819731A0/it
Priority to EP89102569A priority patent/EP0331934A1/en
Application granted granted Critical
Publication of IT1216056B publication Critical patent/IT1216056B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
IT8819731A 1988-03-11 1988-03-11 Composizioni farmaceutiche contenenti timosina alfa 1. IT1216056B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT8819731A IT1216056B (it) 1988-03-11 1988-03-11 Composizioni farmaceutiche contenenti timosina alfa 1.
EP89102569A EP0331934A1 (en) 1988-03-11 1989-02-15 New pharmaceutical compositions containing thymosin alpha 1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8819731A IT1216056B (it) 1988-03-11 1988-03-11 Composizioni farmaceutiche contenenti timosina alfa 1.

Publications (2)

Publication Number Publication Date
IT8819731A0 IT8819731A0 (it) 1988-03-11
IT1216056B true IT1216056B (it) 1990-02-22

Family

ID=11160736

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8819731A IT1216056B (it) 1988-03-11 1988-03-11 Composizioni farmaceutiche contenenti timosina alfa 1.

Country Status (2)

Country Link
EP (1) EP0331934A1 (it)
IT (1) IT1216056B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (it) * 1991-09-13 1994-05-21 Paul B Chretien
CN1072961C (zh) * 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
US6103699A (en) * 1996-06-07 2000-08-15 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
CN100402085C (zh) * 2004-06-23 2008-07-16 北京赛生药业有限公司 高浓度胸腺肽溶液的制备方法及大规格胸腺肽制剂
CN100342909C (zh) * 2005-05-11 2007-10-17 北京双鹭药业股份有限公司 一种胸腺素α1的水溶液制剂、其制备方法及应用
CN102827269B (zh) * 2011-06-13 2017-04-12 中肽生化有限公司 胸腺肽α1的类似物及其制备方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
DE3484374D1 (de) * 1983-08-04 1991-05-08 Green Cross Corp Gamma-interferonzusammensetzung.

Also Published As

Publication number Publication date
EP0331934A1 (en) 1989-09-13
IT8819731A0 (it) 1988-03-11

Similar Documents

Publication Publication Date Title
DE3784594T2 (de) Mikrokapseln enthaltende pharmazeutische Zusammensetzungen.
FR2636238B1 (fr) Nouvelles compositions antisudorales
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
FR2571966B1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
DE68908500T2 (de) Dentalzusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A0 (fi) Farmaceutiska kompositioner.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI872313A (fi) Farmaceutiska kompositioner.
FI883673A (fi) Farmaceutiska kompositioner.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
FI874414A (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
IT1216056B (it) Composizioni farmaceutiche contenenti timosina alfa 1.
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
IT1216814B (it) Composizioni farmaceutiche
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
IT8919844A0 (it) Composizioni farmaceutiche.
IT8619483A0 (it) Composizioni farmaceutiche.
ATE51150T1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970327